Why Global Blood Therapeutics Stock Jumped 10.9% Today

Why Global Blood Therapeutics Stock Jumped 10.9% Today

Source: 
Motley Fool
snippet: 

After disclosing that the Food and Drug Administration has accepted the company's application to review its lead product candidate for approval, shares of Global Blood Therapeutics (NASDAQ: GBT) rallied 10.9% on Thursday.